Psychiatric Comorbidity Related to the Therapy of Male Androgenetic Alopecia Independent of the 5-Alpha Reductase Pathway
October 2021
in “
Skin appendage disorders
”
Research cited in this study
5 / 5 resultsresearch Suicidality and Psychological Adverse Events in Patients Treated with Finasteride
research Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness?
This paper discusses the first reported case of post-finasteride syndrome in a long-term dermatotrichology setting, occurring in a 25-year-old male after dutasteride treatment, and highlights possible links to mental health disorders.
research Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
This review examines medical literature on postfinasteride syndrome and reports no new results; the authors call for more controlled studies on permanent sexual dysfunction and mood changes linked to 5-alpha-reductase inhibitors.
research Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?
In this study, 96% of men with persistent sexual side effects from finasteride reported continued dysfunction after discontinuation, suggesting these effects may endure long-term.
research Personality Disorders and Psychopathologic Symptoms in Patients With Androgenetic Alopecia
This study found that the prevalence of personality disorders in individuals with androgenetic alopecia was significantly higher than in the general population, irrespective of gender.
Similar Research
5 / 1000+ results
research Beyond the Follicle: Exploring Psychiatric Comorbidities in Androgenetic Alopecia
This systematic review found that patients with androgenetic alopecia have an elevated prevalence of psychiatric conditions, which may increase their susceptibility to post-finasteride syndrome symptoms.
research Clinical Patterns of Hair Loss in Men
This article reviews potential therapeutic targets and comorbidities associated with male androgenetic alopecia, but reports no new clinical results; further study is needed for comprehensive management.
research Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: a global propensity score matched retrospective cohort study
Taking medication for hair loss might cause sexual problems.
research Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia
This study found that personality disorders, more than gender, were associated with psychopathologic reactions to androgenetic alopecia.
research Psychosocial Impairment as a Possible Cause of Sexual Dysfunction among Young Men with Mild Androgenetic Alopecia: A Cross-sectional Crowdsourcing Web-based Study.
This study found that men aged 18-40 with moderate to severe psychosocial impairment from male androgenetic alopecia had a higher risk of sexual dysfunction.